Drugs / Hydrogel
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT03816618 | Jan 2020 → Feb 2023 | — | Cyberjaya University College of Medical Sciences | Completed | No outcome recorded |
| Phase 21 trial · 1 met primary | ||||||
| Phase 2 | NCT00435253 | Feb 2007 → Jun 2009 | pulmonary emphysema | Aeris Therapeutics | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hydrogel | “BLVR Treatment, 10 mL Hydrogel” NCT00435253 ↗ |
| Known as | BioLVR hydrogel | “Assess the safety and therapeutic dose of BioLVR hydrogel in upper lobe predominant emphysema.” PMID 19179484 ↗ Jan 2009 |
| Route | Topical | “2nd group will be treated with topical Hydrogel (purloin) gel and empiric antibiotic (systematic)” NCT03816618 ↗ |